USE OF TRIFLUOPERAZINE IN CHRONIC NEGRO SCHIZOPHRENICS
MARSHALL C. SEXTON M.D.1
1 Florida State Hospital, Chattahoochee, Fla.
It is realized that only tentative conclusions can be drawn from such a small series. We can say, however, that our results thus far are encouraging and in some cases quite dramatic. Prompt initial improvement in such difficult cases and in such small dosage makes further study seem imperative. Indeed, we have now undertaken investigation of the effects of trifluoperazine on a much larger group in our patients over a more extended period. The absence so far of any serious side symptoms has also been impressive.
